264 related articles for article (PubMed ID: 23041803)
1. Equal efficacy of glucoprotamin and an aldehyde product for environmental disinfection in a hematologic transplant unit: a prospective crossover trial.
Meinke R; Meyer B; Frei R; Passweg J; Widmer AF
Infect Control Hosp Epidemiol; 2012 Nov; 33(11):1077-80. PubMed ID: 23041803
[TBL] [Abstract][Full Text] [Related]
2. Glucoprotamin antimicrobial activity against selected standard antibiotic-resistant bacteria and reference strains used in the assessment of disinfection efficacy.
Chojecka A; Wiercińska O; Röhm-Rodowald E; Kanclerski K; Jakimiak B
Rocz Panstw Zakl Hig; 2015; 66(3):281-8. PubMed ID: 26400126
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of glucoprotamin: a clinical study of a new disinfectant for instruments.
Widmer AE; Frei R
Infect Control Hosp Epidemiol; 2003 Oct; 24(10):762-4. PubMed ID: 14587939
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores.
Barbut F; Menuet D; Verachten M; Girou E
Infect Control Hosp Epidemiol; 2009 Jun; 30(6):507-14. PubMed ID: 19379098
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen peroxide vapor room disinfection and hand hygiene improvements reduce Clostridium difficile infection, methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and extended-spectrum β-lactamase.
Horn K; Otter JA
Am J Infect Control; 2015 Dec; 43(12):1354-6. PubMed ID: 26654237
[TBL] [Abstract][Full Text] [Related]
6. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species.
Weber DJ; Rutala WA; Miller MB; Huslage K; Sickbert-Bennett E
Am J Infect Control; 2010 Jun; 38(5 Suppl 1):S25-33. PubMed ID: 20569853
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of glucoprotamin-containing disinfectants.
Tyski S; Grzybowska W; Grzeszczuk S; Leszczyński P; Staniszewska M; Röhm-Rodowald E; Jakimiak B
Pol J Microbiol; 2009; 58(4):347-53. PubMed ID: 20380145
[TBL] [Abstract][Full Text] [Related]
8. Prospective cluster controlled crossover trial to compare the impact of an improved hydrogen peroxide disinfectant and a quaternary ammonium-based disinfectant on surface contamination and health care outcomes.
Boyce JM; Guercia KA; Sullivan L; Havill NL; Fekieta R; Kozakiewicz J; Goffman D
Am J Infect Control; 2017 Sep; 45(9):1006-1010. PubMed ID: 28431849
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with multidrug-resistant organisms and Clostridium difficile: a secondary analysis of a multicentre cluster randomised controlled trial with crossover design (BETR Disinfection).
Anderson DJ; Moehring RW; Weber DJ; Lewis SS; Chen LF; Schwab JC; Becherer P; Blocker M; Triplett PF; Knelson LP; Lokhnygina Y; Rutala WA; Sexton DJ;
Lancet Infect Dis; 2018 Aug; 18(8):845-853. PubMed ID: 29880301
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of two hydrogen peroxide vapour aerial decontamination systems for enhanced disinfection of meticillin-resistant Staphylococcus aureus, Klebsiella pneumoniae and Clostridium difficile in single isolation rooms.
Ali S; Muzslay M; Bruce M; Jeanes A; Moore G; Wilson AP
J Hosp Infect; 2016 May; 93(1):70-7. PubMed ID: 26944907
[TBL] [Abstract][Full Text] [Related]
11. Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study.
Anderson DJ; Chen LF; Weber DJ; Moehring RW; Lewis SS; Triplett PF; Blocker M; Becherer P; Schwab JC; Knelson LP; Lokhnygina Y; Rutala WA; Kanamori H; Gergen MF; Sexton DJ;
Lancet; 2017 Feb; 389(10071):805-814. PubMed ID: 28104287
[TBL] [Abstract][Full Text] [Related]
12. Clinical and cost effectiveness of eight disinfection methods for terminal disinfection of hospital isolation rooms contaminated with Clostridium difficile 027.
Doan L; Forrest H; Fakis A; Craig J; Claxton L; Khare M
J Hosp Infect; 2012 Oct; 82(2):114-21. PubMed ID: 22902081
[TBL] [Abstract][Full Text] [Related]
13. Postdischarge decontamination of MRSA, VRE, and Clostridium difficile isolation rooms using 2 commercially available automated ultraviolet-C-emitting devices.
Wong T; Woznow T; Petrie M; Murzello E; Muniak A; Kadora A; Bryce E
Am J Infect Control; 2016 Apr; 44(4):416-20. PubMed ID: 26684367
[TBL] [Abstract][Full Text] [Related]
14. Pathogen transfer and high variability in pathogen removal by detergent wipes.
Ramm L; Siani H; Wesgate R; Maillard JY
Am J Infect Control; 2015 Jul; 43(7):724-8. PubMed ID: 25997876
[TBL] [Abstract][Full Text] [Related]
15. Enhanced disinfection leads to reduction of microbial contamination and a decrease in patient colonization and infection.
Rutala WA; Kanamori H; Gergen MF; Knelson LP; Sickbert-Bennett EE; Chen LF; Anderson DJ; Sexton DJ; Weber DJ;
Infect Control Hosp Epidemiol; 2018 Sep; 39(9):1118-1121. PubMed ID: 30060770
[TBL] [Abstract][Full Text] [Related]
16. Experimental evaluation of an automated endoscope reprocessor with in situ generation of peracetic acid for disinfection of semicritical devices.
Sattar SA; Kibbee RJ; Tetro JA; Rook TA
Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1193-9. PubMed ID: 17080376
[TBL] [Abstract][Full Text] [Related]
17. How to eradicate Clostridium difficile from the environment.
Barbut F
J Hosp Infect; 2015 Apr; 89(4):287-95. PubMed ID: 25638358
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of hydrogen peroxide in improving disinfection of ICU rooms.
Blazejewski C; Wallet F; Rouzé A; Le Guern R; Ponthieux S; Salleron J; Nseir S
Crit Care; 2015 Feb; 19(1):30. PubMed ID: 25641219
[TBL] [Abstract][Full Text] [Related]
19. The impact of enhanced cleaning within the intensive care unit on contamination of the near-patient environment with hospital pathogens: a randomized crossover study in critical care units in two hospitals.
Wilson AP; Smyth D; Moore G; Singleton J; Jackson R; Gant V; Jeanes A; Shaw S; James E; Cooper B; Kafatos G; Cookson B; Singer M; Bellingan G
Crit Care Med; 2011 Apr; 39(4):651-8. PubMed ID: 21242793
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of hydrogen peroxide vapor for the inactivation of nosocomial pathogens on porous and nonporous surfaces.
Lemmen S; Scheithauer S; Häfner H; Yezli S; Mohr M; Otter JA
Am J Infect Control; 2015 Jan; 43(1):82-5. PubMed ID: 25564129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
